Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Median P/S Value
$4.29 (As of Today)

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median P/S Value is calculated as trailing twelve months (TTM) revenue per share times 10-Year median P/S ratio. Synageva BioPharma Corp's revenue per share for the trailing twelve months (TTM) ended in Jun. 2014 was $0.28. Synageva BioPharma Corp's 10-Year median P/S ratio is 15.33. Therefore, the Median P/S Value for today is $4.29.

As of today, Synageva BioPharma Corp's share price is $72.40. Synageva BioPharma Corp's median P/S value is $4.29. Therefore, Synageva BioPharma Corp's Price to Median P/S Value Ratio for today is 16.88.

GEVA' s 10-Year Price to Median P/S Value Range
Min: 0.1   Max: 58
Current: 16.88

0.1
58

During the past 13 years, the highest Price to Median P/S Value Ratio of Synageva BioPharma Corp was 58.00. The lowest was 0.10. And the median was 3.64.

GEVA's Price to Median P/S Value is ranked higher than
65% of the 988 Companies
in the Global Biotechnology industry.

( Industry Median: 1.80 vs. GEVA: 16.88 )

Definition

Synageva BioPharma Corp's Median P/S Value for today is calculated as

Median P/S Value=Total Annual Sales / Shares Outstanding*10-Year Median P/S Ratio
=Revenue per Share (TTM)*10-Year Median P/S Ratio
=0.28*15.33
=4.29

10-Year Median P/S Ratio is 15.33.
Synageva BioPharma Corp's revenue per share for the trailing twelve months (TTM) ended in Jun. 2014 was 0.05 (Sep. 2013 ) + 0.11 (Dec. 2013 ) + 0.05 (Mar. 2014 ) + 0.07 (Jun. 2014 ) = $0.28.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company’s value.

Synageva BioPharma Corp's Price to Median P/S Value Ratio for today is calculated as

Price to Median P/S Value=Share Price/Median P/S Value
=72.40/4.29
=16.87

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

P/E Ratio, P/B Ratio, P/S Ratio, Intrinsic Value (DCF Projected), Intrinsic Value (DCF), Intrinsic Value (DE), Graham Number, GAVA


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
medpsvalue 23.9141.5453.20170.7867.6152.281.99106.5410.127.36

Synageva BioPharma Corp Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
medpsvalue 91.6743.849.2010.1211.1911.508.747.365.214.29
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK